Multibagger Cupid shares are likely to be on investors' radar on Thursday, 12 November, as the company posted another solid quarter, led by consumer healthcare and FMCG business.
The company posted a 133% year-on-year jump in Q2 FY27 net profit to ₹56.22 crore, compared with ₹24.13 crore in the year-ago period. For the first half of FY27, net profit surged 156% YoY to ₹100.37 crore from ₹39.14 crore in H1 FY26.
Revenue from operations grew 122% YoY to ₹187.86 crore in Q2 FY27 and 137% to ₹342.58 crore in H1 FY27. EBITDA for H1 FY27 stood at ₹114.83 crore, registering 156% growth year-on-year, while Q2 EBITDA came in at ₹54.77 crore, with a margin of 29%.
Cupid's strong performance was supported by growing contributions from its domestic consumer healthcare and FMCG business, alongside sustained demand in its international healthcare operations.
The domestic business contributed ₹224.64 crore, accounting for 67% of H1 FY27 sales, compared with 41% in FY26. The Consumer Healthcare & FMCG segment alone contributed ₹166.88 crore, representing 49% of sales, highlighting the increasing scale of its consumer portfolio.